Warning Letter — jadepouch.com
The FDA's Center for Tobacco Products issued a warning letter to jadepouch.com following an investigation into the sale of unauthorized tobacco products.
The warning affects jadepouch.com, as well as online retailers, distributors, and compliance officers involved in the sale and marketing of tobacco products.
This action indicates a continued focus by the Center for Tobacco Products on digital storefronts and the online distribution chain. Regulatory teams may view this as a signal that the FDA is prioritizing enforcement against e-commerce entities that fail to verify the marketing authorization status of their inventory. Failure to respond to such warnings typically leads to escalated enforcement, including civil money penalties or permanent injunctions.
Retailers and distributors should conduct an immediate audit of online inventory to ensure all tobacco products have active marketing authorizations. Legal and compliance teams should monitor e-commerce platforms for unauthorized product listings to avoid enforcement actions from the Center for Tobacco Products.
FDA Warning Letter issued to: jadepouch.com. 04/23/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jadepouchcom-728474-04232026
Open in openFDA / FDA.gov